Literature DB >> 33191213

Evaluation of Pyocyanin induced systemic pathogenicity of Pseudomonas aeruginosa.

Muhammad Ibrahim Rashid1, Saadia Andleeb1, Amjad Ali1.   

Abstract

Pseudomonas aeruginosa (PA) is one of the most clinically significant nosocomial infectious agents. Clinical significance of this bacterium is intensified due to the phenomenon of its natural tendency for acquiring drug resistance mechanisms. PA produces pyocyanin (PCN), an important redox-active virulence factor. PCN has been detected in higher quantities in sputum samples of PA infected Cystic Fibrosis patients. PCN producing PA strains were isolated and characterized. Genomic 16s rRNA gene segment was amplified and sequenced (GenBank accession # jx280426). PCN was extracted and purified. In silico analysis yielded permeability and cytotoxic potential of PCN in modeled cell lines. PCN has high intestinal absorption, plasma protein binding potential, and permeability across biological membranes. Oral toxicity study in in silico rodent model classified PCN in class IV 'harmful if swallowed' (ld50 0.3-2g/kg). Cytotoxicity was assessed by oxidative stress levels in different organs in balb/c mice induced by intra peritoneal PCN injection. Significant alterations in oxidative stress levels in different organs of balb/c mice were observed. Increased levels of oxidative stress were observed in lungs, and heart, lower in liver and spleen while muscle tissues showed no significant difference in comparison to control.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33191213

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Quest for Novel Preventive and Therapeutic Options Against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Sidra Irum; Saadia Andleeb; Amjad Ali; Muhammad Ibrahim Rashid; Mahnoor Majid
Journal:  Int J Pept Res Ther       Date:  2021-08-09       Impact factor: 1.931

2.  Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction.

Authors:  Roberta Peruzzo; Samantha Corrà; Roberto Costa; Michele Brischigliaro; Tatiana Varanita; Lucia Biasutto; Chiara Rampazzo; Daniele Ghezzi; Luigi Leanza; Mario Zoratti; Massimo Zeviani; Cristiano De Pittà; Carlo Viscomi; Rodolfo Costa; Ildikò Szabò
Journal:  Nat Commun       Date:  2021-04-08       Impact factor: 17.694

3.  Evaluation of Blood-Brain-Barrier Permeability, Neurotoxicity, and Potential Cognitive Impairment by Pseudomonas aeruginosa's Virulence Factor Pyocyanin.

Authors:  Muhammad Ibrahim Rashid; Habiba Rashid; Saadia Andleeb; Amjad Ali
Journal:  Oxid Med Cell Longev       Date:  2022-03-17       Impact factor: 6.543

4.  Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach.

Authors:  Glauber V Da Costa; Moysés F A Neto; Alicia K P Da Silva; Ester M F De Sá; Luanne C F Cancela; Jeanina S Vega; Cássio M Lobato; Juliana P Zuliani; José M Espejo-Román; Joaquín M Campos; Franco H A Leite; Cleydson B R Santos
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.